Zobrazeno 1 - 10
of 259
pro vyhledávání: '"Stuart M. Lichtman"'
Autor:
Avni M. Desai, Stuart M. Lichtman
Publikováno v:
Cancer Biology & Medicine, Vol 12, Iss 4, Pp 284-291 (2015)
In the coming years life expectancy is expected to increase and with this the percentage of the population above age 65 will grow. Patients above 65 make up more than two thirds of those currently diagnosed with gastrointestinal malignancies. Availab
Externí odkaz:
https://doaj.org/article/84602a87609c4b9586b42b2e85e7e3db
Publikováno v:
Cancer Biology & Medicine, Vol 12, Iss 4, Pp 292-301 (2015)
Epithelial ovarian cancer is primarily a disease of older women. Advanced age is risk factor for decreased survival. Optimal surgery and the safe and effective administration of chemotherapy are essential for prolonged progression-free and overall su
Externí odkaz:
https://doaj.org/article/b225ec6784da4718819fdb0dabf92c63
Autor:
Tiffany Y. Sia, William P. Tew, Christopher Purdy, Dennis S. Chi, Andrew W. Menzin, John L. Lovecchio, Michael A. Bookman, David E. Cohn, Deanna G. Teoh, Michael Friedlander, David Bender, David G. Mutch, David M. Gershenson, Krishnansu S. Tewari, Robert M. Wenham, Andrea E. Wahner Hendrickson, Roger B. Lee, Heidi J. Gray, Angeles Alvarez Secord, Linda Van Le, Stuart M. Lichtman
Publikováno v:
Gynecologic Oncology. 173:130-137
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef60aebf275e86601e565bb15a73080b
https://doi.org/10.1016/j.ygyno.2023.03.018
https://doi.org/10.1016/j.ygyno.2023.03.018
Autor:
Ben Sprangers, ProfPhD, Annelien Van der Veen, Marije E Hamaker, PhD, Siri Rostoft, ProfPhD, Sheron Latcha, MD, Stuart M Lichtman, ProfMD, Bart de Moor, MD, Hans Wildiers, ProfPhD
Publikováno v:
The Lancet. Healthy Longevity, Vol 2, Iss 1, Pp e42-e52 (2021)
Summary: Cancer and chronic kidney disease prevalence both increase with age. As a consequence, physicians are more frequently encountering older people with cancer who need dialysis, or patients on dialysis diagnosed with cancer. Decisions in this c
Externí odkaz:
https://doaj.org/article/68d51f9efa45402f9f8d3d565bcb57fe
Autor:
Francis Ho, Alfred Kow, Wan Chin Lim, Matthew Zhixuan Chen, Nydia Camelia Mohd Rais, Natalie Mun Wai Ling, Melissa Ooi, Jing Yu Ng, Yean Shin Ng, Meiling Chun, Yao Yao, Noorhanah Mohd Said, Wan Nghee Eng, Wen Meei Chen, Vivian Luah, Yijun Loy, Jiexin Ong, Wei Yee Wong, Beatriz Korc-Grodzicki, Stuart M Lichtman, Angela Pang
Publikováno v:
The Oncologist. 28:e198-e204
Introduction In the National University Cancer Institute, Singapore (NCIS), 2 pilot programs providing (i) surgical prehabilitation before cancer surgery and (ii) geriatric oncology support for older adults planned for chemotherapy and/or radiotherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79cf08f0aa2ac40f3bafe5d52c6532e8
https://doi.org/10.1093/oncolo/oyac276
https://doi.org/10.1093/oncolo/oyac276
Publikováno v:
J Geriatr Oncol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc7452640e54c7db83635715995bc697
https://doi.org/10.1016/j.jgo.2021.09.002
https://doi.org/10.1016/j.jgo.2021.09.002
Autor:
Harvey J. Cohen, Noam A. VanderWalde, Jacqueline M. Lafky, Reshma Jagsi, Travis J. Dockter, Stuart M. Lichtman, Jeff A. Sloan, Jennifer Le-Rademacher, Daniel Satele, Daniel V. Wakefield, Rachel A. Freedman, Hyman B. Muss, Aminah Jatoi
Publikováno v:
J Geriatr Oncol
BACKGROUND: Older adults are under-represented in cancer clinical trials. However, it remains unclear which types of trials under-enroll aging patients. We aimed to identify associations between trial characteristics and disparate enrollment of older
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32c792d8d41fd9d785d3b6d5ac3f481b
https://doi.org/10.1016/j.jgo.2021.07.008
https://doi.org/10.1016/j.jgo.2021.07.008
Chemotherapeutic agents used to treat cancer generally have narrow therapeutic indices along with potentially serious adverse toxicities. Many cancer drugs are at least partially excreted through the kidney and, thus, the availability of accurate dat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e40d492f822b62ce656c19dd36e65060
https://lirias.kuleuven.be/handle/20.500.12942/703390
https://lirias.kuleuven.be/handle/20.500.12942/703390
Autor:
Nicolò Matteo Luca Battisti, Nienke De Glas, Enrique Soto-Perez-de-Celis, Gabor Liposits, Michael Bringuier, Christine Walko, Stuart M. Lichtman, Matti Aapro, Kwok-Leung Cheung, Laura Biganzoli, Alistair Ring, Johanneke Portielje, Hans Wildiers, Etienne Brain
Publikováno v:
European Journal of Cancer, 172, 158-170. ELSEVIER SCI LTD
Background: The benefit of chemotherapy for older patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer (EBC) is a key area of debate. Gene expression profiling (GEP) may identify p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7823abe59e39410bfcb7ccc6dfdebe4
https://hdl.handle.net/1887/3566672
https://hdl.handle.net/1887/3566672
Publikováno v:
J Clin Oncol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1339d6730d747cff5dfecce3280dfca
https://doi.org/10.1200/jco.21.00317
https://doi.org/10.1200/jco.21.00317